This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutton, R. E.
Right arrow Articles by Littman, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutton, R. E.
Right arrow Articles by Littman, D. R.

 Previous Article  |  Next Article 

J. Virol., 10 1996, 7322-7326, Vol 70, No. 10
Copyright © 1996, American Society for Microbiology

Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system

RE Sutton and DR Littman
Howard Hughes Medical Institute, Stanford University, California 94305, USA.

Studies of human T-cell leukemia virus type 1 (HTLV-1) have been hampered by the difficulty of achieving high cell-free and cell- associated infectious titers. Current retroviral pseudotyping systems using the HTLV-1 envelope generate titers of less than 200 infectious particles per ml. We describe here an improved system for pseudotyping using a defective human immunodeficiency virus (HIV) type 1 genome in combination with HTLV-1 env in 293T producer cells. Introduction of additional copies of rev and treatment of cells with sodium butyrate resulted in a cell-associated titer of 10(5)/ml and cell-free titers of greater than 10(4)/ml . By using this system, we found that the host range of HTLV-1 is even greater than previously suspected. Earlier studies which assigned a chromosomal location for the HTLV-1 receptor may therefore reflect cell-to-cell variation in receptor number rather than the absolute presence or absence of a receptor. The generation of higher-titer HIV(HTLV-1) may facilitate identification of the cellular receptor and investigations of the pathophysiology of HTLV-1 infection.


This article has been cited by other articles:

  • Lavanya, M., Kinet, S., Montel-Hagen, A., Mongellaz, C., Battini, J.-L., Sitbon, M., Taylor, N. (2008). Cell Surface Expression of the Bovine Leukemia Virus-Binding Receptor on B and T Lymphocytes Is Induced by Receptor Engagement. J. Immunol. 181: 891-898 [Abstract] [Full Text]  
  • Takenouchi, N., Jones, K. S., Lisinski, I., Fugo, K., Yao, K., Cushman, S. W., Ruscetti, F. W., Jacobson, S. (2007). GLUT1 Is Not the Primary Binding Receptor but Is Associated with Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1. J. Virol. 81: 1506-1510 [Abstract] [Full Text]  
  • Jones, K. S., Fugo, K., Petrow-Sadowski, C., Huang, Y., Bertolette, D. C., Lisinski, I., Cushman, S. W., Jacobson, S., Ruscetti, F. W. (2006). Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Use Different Receptor Complexes To Enter T Cells.. J. Virol. 80: 8291-8302 [Abstract] [Full Text]  
  • Ghez, D., Lepelletier, Y., Lambert, S., Fourneau, J.-M., Blot, V., Janvier, S., Arnulf, B., van Endert, P. M., Heveker, N., Pique, C., Hermine, O. (2006). Neuropilin-1 Is Involved in Human T-Cell Lymphotropic Virus Type 1 Entry. J. Virol. 80: 6844-6854 [Abstract] [Full Text]  
  • Coskun, A. K., van Maanen, M., Nguyen, V., Sutton, R. E. (2006). Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.. J. Virol. 80: 3406-3415 [Abstract] [Full Text]  
  • Xie, L., Green, P. L. (2005). Envelope Is a Major Viral Determinant of the Distinct In Vitro Cellular Transformation Tropism of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2. J. Virol. 79: 14536-14545 [Abstract] [Full Text]  
  • Jones, K. S., Petrow-Sadowski, C., Bertolette, D. C., Huang, Y., Ruscetti, F. W. (2005). Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T Cells. J. Virol. 79: 12692-12702 [Abstract] [Full Text]  
  • Martin, F., Roth, D. M., Jans, D. A., Pouton, C. W., Partridge, L. J., Monk, P. N., Moseley, G. W. (2005). Tetraspanins in Viral Infections: a Fundamental Role in Viral Biology?. J. Virol. 79: 10839-10851 [Full Text]  
  • Manel, N., Battini, J.-L., Sitbon, M. (2005). Human T Cell Leukemia Virus Envelope Binding and Virus Entry Are Mediated by Distinct Domains of the Glucose Transporter GLUT1. J. Biol. Chem. 280: 29025-29029 [Abstract] [Full Text]  
  • Coskun, A. K., Sutton, R. E. (2005). Expression of Glucose Transporter 1 Confers Susceptibility to Human T-Cell Leukemia Virus Envelope-Mediated Fusion. J. Virol. 79: 4150-4158 [Abstract] [Full Text]  
  • Jones, K. S., Akel, S., Petrow-Sadowski, C., Huang, Y., Bertolette, D. C., Ruscetti, F. W. (2005). Induction of Human T Cell Leukemia Virus Type I Receptors on Quiescent Naive T Lymphocytes by TGF-{beta}. J. Immunol. 174: 4262-4270 [Abstract] [Full Text]  
  • Agrawal, L., Lu, X., Qingwen, J., VanHorn-Ali, Z., Nicolescu, I. V., McDermott, D. H., Murphy, P. M., Alkhatib, G. (2004). Role for CCR5{Delta}32 Protein in Resistance to R5, R5X4, and X4 Human Immunodeficiency Virus Type 1 in Primary CD4+ Cells. J. Virol. 78: 2277-2287 [Abstract] [Full Text]  
  • Zhang, X.-Y., La Russa, V. F., Reiser, J. (2004). Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by Using Lentivirus Vectors Pseudotyped with Modified RD114 Envelope Glycoproteins. J. Virol. 78: 1219-1229 [Abstract] [Full Text]  
  • Pinon, J. D., Klasse, P. J., Jassal, S. R., Welson, S., Weber, J., Brighty, D. W., Sattentau, Q. J. (2003). Human T-Cell Leukemia Virus Type 1 Envelope Glycoprotein gp46 Interacts with Cell Surface Heparan Sulfate Proteoglycans. J. Virol. 77: 9922-9930 [Abstract] [Full Text]  
  • Nath, M. D., Ruscetti, F. W., Petrow-Sadowski, C., Jones, K. S. (2003). Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood 101: 3085-3092 [Abstract] [Full Text]  
  • Pinon, J. D., Kelly, S. M., Price, N. C., Flanagan, J. U., Brighty, D. W. (2003). An Antiviral Peptide Targets a Coiled-Coil Domain of the Human T-Cell Leukemia Virus Envelope Glycoprotein. J. Virol. 77: 3281-3290 [Abstract] [Full Text]  
  • Manel, N., Kinet, S., Battini, J.-L., Kim, F. J., Taylor, N., Sitbon, M. (2003). The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 101: 1913-1918 [Abstract] [Full Text]  
  • Kim, F. J., Manel, N., Boublik, Y., Battini, J.-L., Sitbon, M. (2002). Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation Can Be Activated in Resistant Mammalian Cell Lines by a Carboxy-Terminal Truncation of the Envelope Cytoplasmic Domain. J. Virol. 77: 963-969 [Abstract] [Full Text]  
  • Jones, K. S., Nath, M., Petrow-Sadowski, C., Baines, A. C., Dambach, M., Huang, Y., Ruscetti, F. W. (2002). Similar Regulation of Cell Surface Human T-Cell Leukemia Virus Type 1 (HTLV-1) Surface Binding Proteins in Cells Highly and Poorly Transduced by HTLV-1-Pseudotyped Virions. J. Virol. 76: 12723-12734 [Abstract] [Full Text]  
  • Gatot, J.-S., Callebaut, I., Van Lint, C., Demonte, D., Kerkhofs, P., Portetelle, D., Burny, A., Willems, L., Kettmann, R. (2002). Bovine Leukemia Virus SU Protein Interacts with Zinc, and Mutations within Two Interacting Regions Differently Affect Viral Fusion and Infectivity In Vivo. J. Virol. 76: 7956-7967 [Abstract] [Full Text]  
  • Delebecque, F., Pramberger, K., Prevost, M.-C., Brahic, M., Tangy, F. (2002). A Chimeric Human T-Cell Lymphotropic Virus Type 1 with the Envelope Glycoprotein of Moloney Murine Leukemia Virus Is Infectious for Murine Cells. J. Virol. 76: 7883-7889 [Abstract] [Full Text]  
  • Hakata, Y., Yamada, M., Shida, H. (2001). Rat CRM1 Is Responsible for the Poor Activity of Human T-Cell Leukemia Virus Type 1 Rex Protein in Rat Cells. J. Virol. 75: 11515-11525 [Abstract] [Full Text]  
  • Brighty, D. W., Jassal, S. R. (2001). The Synthetic Peptide P-197 Inhibits Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation by a Mechanism That Is Independent of Hsc70. J. Virol. 75: 10472-10478 [Abstract] [Full Text]  
  • Derse, D., Hill, S. A., Lloyd, P. A., Chung, H.-k., Morse, B. A. (2001). Examining Human T-Lymphotropic Virus Type 1 Infection and Replication by Cell-Free Infection with Recombinant Virus Vectors. J. Virol. 75: 8461-8468 [Abstract] [Full Text]  
  • Jassal, S. R., Pohler, R. G., Brighty, D. W. (2001). Human T-Cell Leukemia Virus Type 1 Receptor Expression among Syncytium-Resistant Cell Lines Revealed by a Novel Surface Glycoprotein-Immunoadhesin. J. Virol. 75: 8317-8328 [Abstract] [Full Text]  
  • Niyogi, K., Hildreth, J. E. K. (2001). Characterization of New Syncytium-Inhibiting Monoclonal Antibodies Implicates Lipid Rafts in Human T-Cell Leukemia Virus Type 1 Syncytium Formation. J. Virol. 75: 7351-7361 [Abstract] [Full Text]  
  • Hotzel, I., Cheevers, W. P. (2001). Host Range of Small-Ruminant Lentivirus Cytopathic Variants Determined with a Selectable Caprine Arthritis- Encephalitis Virus Pseudotype System. J. Virol. 75: 7384-7391 [Abstract] [Full Text]  
  • Okuma, K., Matsuura, Y., Tatsuo, H., Inagaki, Y., Nakamura, M., Yamamoto, N., Yanagi, Y. (2001). Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins. J. Gen. Virol. 82: 821-830 [Abstract] [Full Text]  
  • Daenke, S, Booth, S (2000). HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding. J. Cell Sci. 113: 37-44 [Abstract]  
  • Sommerfelt, M. A. (1999). Retrovirus receptors. J. Gen. Virol. 80: 3049-3064 [Full Text]  
  • Sutton, R. E., Reitsma, M. J., Uchida, N., Brown, P. O. (1999). Transduction of Human Progenitor Hematopoietic Stem Cells by Human Immunodeficiency Virus Type 1-Based Vectors Is Cell Cycle Dependent. J. Virol. 73: 3649-3660 [Abstract] [Full Text]  
  • Park, E. J., Vujcic, L. K., Anand, R., Theodore, T. S., Quinnan, G. V. Jr. (1998). Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes. J. Virol. 72: 7099-7107 [Abstract] [Full Text]  
  • Rosenberg, A. R., Delamarre, L., Preira, A., Dokhelar, M.-C. (1998). Analysis of Functional Conservation in the Surface and Transmembrane Glycoprotein Subunits of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2. J. Virol. 72: 7609-7614 [Abstract] [Full Text]  
  • Sutton, R. E., Wu, H. T. M., Rigg, R., Bohnlein, E., Brown, P. O. (1998). Human Immunodeficiency Virus Type 1 Vectors Efficiently Transduce Human Hematopoietic Stem Cells. J. Virol. 72: 5781-5788 [Abstract] [Full Text]  
  • Fang, J., Kushida, S., Feng, R., Tanaka, M., Kawamura, T., Abe, H., Maeda, N., Onobori, M., Hori, M., Uchida, K., Miwa, M. (1998). Transmission of Human T-Cell Leukemia Virus Type 1 to Mice. J. Virol. 72: 3952-3957 [Abstract] [Full Text]  
  • Wool-Lewis, R. J., Bates, P. (1998). Characterization of Ebola Virus Entry by Using Pseudotyped Viruses: Identification of Receptor-Deficient Cell Lines. J. Virol. 72: 3155-3160 [Abstract] [Full Text]  
  • Sagara, Y., Ishida, C., Inoue, Y., Shiraki, H., Maeda, Y. (1998). 71-Kilodalton Heat Shock Cognate Protein Acts as a Cellular Receptor for Syncytium Formation Induced by Human T-Cell Lymphotropic Virus Type 1. J. Virol. 72: 535-541 [Abstract] [Full Text]  
  • Kim, F. J., Seiliez, I., Denesvre, C., Lavillette, D., Cosset, F.-L., Sitbon, M. (2000). Definition of an Amino-terminal Domain of the Human T-cell Leukemia Virus Type 1 Envelope Surface Unit That Extends the Fusogenic Range of an Ecotropic Murine Leukemia Virus. J. Biol. Chem. 275: 23417-23420 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»